Mechanism for immune-mediated drug-induced thrombotic microangiopathy (DITMA) and other systemic reactions caused by quinine
Mechanism for immune-mediated drug-induced thrombotic microangiopathy (DITMA) and other systemic reactions caused by quinine
(A) Naturally occurring antibodies that react very weakly with antigens on autologous cells* may be present in certain individuals. (B) Drugs can bind to the complementarity-determining regions (CDR) of the naturally occurring antibodies, remodeling their structure and increasing their binding affinity to the antigenic epitopes by >10,000-fold. The physiologic response to antigen-antibody binding provokes cell injury and TMA. These antibodies persist for years; subsequent drug exposure can cause an immediate reaction.
CDR: complementarity-determining region; GP IIb/IIIa: platelet glycoprotein IIb/IIIa; TMA: thrombotic microangiopathy. * Quinine-dependent antibodies have been demonstrated to bind platelet glycoprotein alphaIIb-beta3 (GP IIb/IIIa), and it is assumed that this mechanism also occurs on vascular endothelial cells and other tissues. Refer to the source document and UpToDate for additional citations.